Actively Recruiting
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
Led by Anhui Provincial Cancer Hospital · Updated on 2026-04-13
12
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
Sponsors
A
Anhui Provincial Cancer Hospital
Lead Sponsor
A
Anhui Provincial Hospital
Collaborating Sponsor
AI-Summary
What this Trial Is About
This study was a single-center, single-arm clinical study to evaluate the safety and efficacy of hypervision proton surgery with single large fractionated doses (34GyE and 39GyE) in the treatment of early peripheral NSCLC.
CONDITIONS
Official Title
To Explore the Safety and Efficacy of Hypervision Proton Surgery for Early-stage Non-small Cell Lung Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years old
- Karnofsky Performance Status greater than 80
- NSCLC confirmed by cytology or histology, or clinical diagnosis by multidisciplinary team if biopsy is unsafe
- Early-stage tumor defined as T1 (3 cm or smaller) N0M0 by enhanced CT and PET
- Tumor located more than 2 cm from the proximal bronchial tree in all directions
- FEV1 at least 1 L or 40% of predicted value
- DLCO at least 40% of predicted value
- Able to tolerate PET-CT examination
- For women of childbearing age, negative urine or serum pregnancy test within 7 days before treatment start
You will not qualify if you...
- Other malignant tumors within 2 years before enrollment
- History of chest radiotherapy
- Planned use of other anti-tumor treatments within 4 weeks of study treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Anhui Provincial Hospital
Hefei, Anhui, China, 230001
Actively Recruiting
Research Team
S
Shuanghu Yuan, PhD
CONTACT
L
Li Li, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here